NK2 homeobox 4 (NKX2-4)

NK2 homeobox 4 (NKX2-4) encodes a DNA-binding homeobox transcription factor expressed primarily in the nucleus, involved in the regulation of gene expression during early development, including differentiation of neural and endocrine tissues[2][3][5][7]. It has structural homology with other NK-like homeobox proteins, such as NKX2-1 (critical for lung and thyroid development), but NKX2-4 itself is less well studied. While not an established therapeutic target, variants or aberrant expression of NKX2-4 have been linked to rare developmental disorders (such as congenital hypothyroidism and diabetes mellitus of neonatal onset) and certain cancers (such as lung sarcomatoid carcinoma)[2][3]. This transcription factor is typically localized to the nucleus and regulates programs of gene transcription in a sequence-specific manner, controlling cellular differentiation and potentially contributing to developmental tissue patterning[2][5][7].

Other names

NKX2-4NKX2DNKX2.4Homeobox protein Nkx-2.4NK2 transcription factor homolog DNK2 homeobox 4b

Not applicable. There are no drugs targeting NKX2-4, so no mechanisms of action are described.